首页> 外文期刊>The American Journal of Cardiology >Additive Prognostic Value of Coronary Artery Calcium Score Over Coronary Computed Tomographic Angiography Stenosis Assessment in Symptomatic Patients Without Known Coronary Artery Disease
【24h】

Additive Prognostic Value of Coronary Artery Calcium Score Over Coronary Computed Tomographic Angiography Stenosis Assessment in Symptomatic Patients Without Known Coronary Artery Disease

机译:在没有已知冠状动脉疾病的有症状患者中,冠状动脉钙化分数对冠状动脉计算机断层造影血管狭窄评估的附加预后价值

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to examine the additive prognostic performance of coronary artery calcium score (CACS) over coronary computed tomography angiography (CCTA) stenosis assessment in symptomatic patients suspected for coronary artery disease (CAD) undergoing CCTA. A total of 805 symptomatic patients without known history of CAD who underwent coronary evaluation by multidetector cardiac CT were analyzed. Mean age of the cohort was 58 13 years. A total of 44% (354 of 805) of the patients had a 0 CACS, 27% (215 of 805) had CACS 1 to 100, 14% (111 of 805) had CACS 101 to 400, and 15% (125 of 805) had CACS >400. CCTA showed normal coronary arteries in 43% (349 of 805) of patients, 550% stenosis in 42% (333 of 805), and >50% stenosis in 15% (123 of 805). Patients were followed for 2.3 +/- 0.9 years. Major adverse cardiac event (MACE) was defined as cardiac death, nonfatal myocardial infarction, and late coronary revascularization. Overall incidence of MACE was 1.4% per year. Both CACS and CCTA stenosis were independently associated with increased MACE (p <0.05 for both). Addition of CACS into the model with clinical risk factors and CCTA stenosis significantly improved predictive performance for MACE from the model with clinical risk factors and CCTA stenosis only (global chi-square score 108 vs 70; p = 0.019). In conclusion; in symptomatic patients without known CAD, both CACS and CCTA stenosis were independently associated with increased cardiac events, and performing non contrast-enhanced CACS evaluation in addition to contrast-enhanced CCTA improved predictive ability for future cardiac events compared to CCTA stenosis assessment alone. (C) 2015 Elsevier Inc. All rights reserved.
机译:这项研究的目的是检查怀疑患有CCTA的有症状冠心病(CAD)的有症状患者,冠状动脉钙化评分(CACS)优于冠状动脉计算机断层扫描血管造影(CCTA)狭窄评估的预后。总共分析了805例无CAD史的症状患者,这些患者通过多探测器心脏CT进行了冠状动脉评估。该队列的平均年龄为58 13岁。共有44%(805的354)患者的CACS为0,27%(805的215)的CACS为1至100,14%(805的111)的CACS为101-400,15%(125的125) 805)的CACS> 400。 CCTA显示43%(805的349)患者的冠状动脉正常,42%(805的333)的患者550%狭窄,15%(805的123)的患者狭窄> 50%。对患者进行了2.3 +/- 0.9年的随访。严重不良心脏事件(MACE)定义为心脏死亡,非致命性心肌梗塞和晚期冠脉血运重建。 MACE的总发生率为每年1.4%。 CACS和CCTA狭窄均与MACE升高独立相关(两者均p <0.05)。将CACS添加到具有临床危险因素和CCTA狭窄的模型中,与仅具有临床危险因素和CCTA狭窄的模型相比,显着改善了MACE的预测性能(总体卡方评分为108 vs 70; p = 0.019)。结论;在没有已知CAD的有症状患者中,CACS和CCTA狭窄均与心脏事件增加独立相关,并且与单独CCTA狭窄评估相比,CCAT增强和非造影剂CACS评估对未来心脏事件的预测能力也得到了增强。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号